Institutional Ownership
Aytu Biopharma Inc
CUSIP 054754858COMAYTUQ1 2026
13D / 13G Filings
17
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
19.7%
Max % of class reported
Institutional Holders
34
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
17 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Lytton Laurence W | 13G/A | 10.0% | 1.07T | SEC |
| 2 | Nov 14, 2025 | Lytton Laurence W | 13G/A | 10.0% | 10.87T | SEC |
| 3 | Nov 12, 2025 | Philotimo Fund, LP | 13G/A | — | — | SEC |
| 4 | Aug 13, 2025 | Stonepine Capital Management, LLC | 13G/A | 9.9% | — | SEC |
| 5 | Jun 26, 2025 | Philotimo Fund, LP | 13G | 6.4% | 573.4K | SEC |
| 6 | Jun 26, 2025 | Philotimo Fund, LP | 13G/A | 2.7% | 166.3K | SEC |
| 7 | Jun 26, 2025 | Philotimo Fund, LP | 13G/A | 10.3% | 635.1K | SEC |
| 8 | Jun 26, 2025 | Philotimo Fund, LP | 13G | 6.2% | 381.8K | SEC |
| 9 | Jun 13, 2025 | Lytton Laurence W | 13G | 5.6% | 506.6K | SEC |
| 10 | Jun 9, 2025 | Nantahala Capital Management, LLC | 13D/A | 14.4% | — | SEC |
7 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Aytu Biopharma Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Nantahala Capital Management, LLC | 1.09M | $2.97M |
| 2 | Stonepine Capital Management, LLC | 792.3K | $2.16M |
| 3 | Awm Investment Company, Inc. | 619.6K | $1.69M |
| 4 | Diadema Partners LP | 353.1K | $963.9K |
| 5 | Two Sigma Investments, LP | 122.0K | $333.0K |
| 6 | Renaissance Technologies LLC | 93.7K | $255.9K |
| 7 | Persistent Asset Partners Ltd | 92.9K | $253.6K |
| 8 | Geode Capital Management, LLC | 92.6K | $252.9K |
| 9 | Dimensional Fund Advisors LP | 43.6K | $119.0K |
| 10 | Citadel Advisors LLC | 36.8K | $100.6K |